Trial Profile
Phase 1 study to Evaluate the drug-drug interaction among Ombitasvir/ Paritaprevir/Ritonavir +/− Dasabuvir and Sofosbuvir
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Dec 2015
Price :
$35
*
At a glance
- Drugs Dasabuvir (Primary) ; Ombitasvir/paritaprevir/ritonavir (Primary) ; Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Pharmacokinetics
- 23 Nov 2015 Results published in the Antimicrobial Agents and Chemotherapy
- 13 Aug 2015 New trial record